Recombinant Human Hexosaminidase A/HEXA Protein, CF
R&D Systems | Catalog # 6237-GH
Key Product Details
- R&D Systems Sf 21 (baculovirus)-derived Recombinant Human Hexosaminidase A/HEXA Protein (6237-GH)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
Accession Number
Applications
Product Specifications
Source
Met1-Thr529, with a C-terminal 6-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The specific activity is >1,250 pmol/min/μg, as measured under the described conditions.
Formulation, Preparation, and Storage
6237-GH
| Formulation | Supplied as a 0.2 μm filtered solution in Tris and NaCl. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Hexosaminidase A/HEXA
(1‑4). The enzymes are composed of two alpha and/or beta subunits, which are coded by HEXA and HEXB genes, respectively. Different association of the alpha and beta subunits gives rise to beta ‑hexosaminidase isoforms A, B and S (Hex A, B and S) (5), which have the composition of alpha beta, beta beta and alpha alpha, respectively. Our recombinant HEXA is presumably isoform Hex S, because only alpha subunit was expressed. Hex S is suggested to releases non‑reducing end N-acetylgalactosamine residues from dermatan sulfate, chondroitin sulfate and sulfated glycolipid SM2 (6). Recombinant HEXA is also highly active on 4-methylumbelliferyl-N-acetyl-beta -D-glucosaminide (6). Mutations in HEXA and HEXB genes cause lysosomal lipid storage disorders. Specifically, mutations of HEXA cause Tay-Sachs disease, manifested by the harmful accumulation of ganglioside GM2 in tissues and nerve cells in the brain (7‑10). Children with this disease usually die by age 4.
References
- Gilbert, F. et al. (1975) Proc. Natl. Acad. Sci. USA 72:263.
- Myerowitz, R. et al. (1985) Proc. Natl. Acad. Sci. USA 82:7830.
- Korneluk, R.G. et al. (1986) J. Biol. Chem. 261:8407.
- Mark, B.L. et al. (2003) J. Mol. Biol. 327:1093.
- Mahuran, D.J. et al. (1988) J. Biol. Chem. 263:4612.
- Hepbildikler, S.T. et al. (2002) J. Biol. Chem. 277:2562.
- Mahuran, D.J. (1991) Biochim. Biophys. Acta 1096:87.
- Mencarelli, S. et al. (2005) FEBS Lett. 579:5501.
- Neufeld, E.F. (1989) J. Biol. Chem. 264:10927.
- Ohno, K. et al. (2008) Mol. Genet. Metab. 94:462.
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional Hexosaminidase A/HEXA Products
Product Documents for Recombinant Human Hexosaminidase A/HEXA Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Human Hexosaminidase A/HEXA Protein, CF
For research use only
Related Research Areas
Citations for Recombinant Human Hexosaminidase A/HEXA Protein, CF
Customer Reviews for Recombinant Human Hexosaminidase A/HEXA Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Hexosaminidase A/HEXA Protein, CF and earn rewards!
Have you used Recombinant Human Hexosaminidase A/HEXA Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant Human Hexosaminidase A/HEXA Protein, CF (6237-GH):
- Assay Buffer: 100 mM Sodium Citrate, 250 mM NaCl, pH 4.5
- Recombinant Human Hexosaminidase A/HEXA (rhHEXA) (Catalog # 6237-GH)
- Substrate: 4-Methylumbelliferyl-N-Acetyl-beta -D-glucosaminide (4-MU-GlcNAc) (Sigma, Catalog # M2133), 50 mM stock in DMSO
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
- Dilute rhHEXA to 5 ng/μL in Assay Buffer.
- Dilute Substrate to 800 μM in Assay Buffer.
- Load into a plate 50 μL of 5 ng/μL rhHEXA, and start the reaction by adding 50 μL of 800 μM Substrate. For Substrate Blanks, load 50 μL of Assay Buffer and 50 μL of 800 μM Substrate.
- Read plate at excitation and emission wavelengths of 365 nm and 445 nm, respectively, in kinetic mode for 5 minutes.
- Calculate specific activity:
|
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
| amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Derived using calibration standard 4-Methylumbelliferone (4-MU) (Sigma, Catalog # M1381).
- rhHEXA: 0.250 μg
- Substrate: 400 μM